Fractional flow reserve in patients with reduced ejection fraction.

AIMS Fractional flow reserve (FFR) has never been investigated in patients with reduced ejection fraction and associated coronary artery disease (CAD). We evaluated the impact of FFR on the management strategies of these patients and related outcomes. METHODS AND RESULTS From 2002 to 2010, all consecutive patients with left ventricular ejection fraction (LVEF) ≤50% undergoing coronary angiography with ≥1 intermediate coronary stenosis [diameter stenosis (DS)% 50-70%] treated based on angiography (Angiography-guided group) or according to FFR (FFR-guided group) were screened for inclusion. In the FFR-guided group, 433 patients were matched with 866 contemporary patients of the Angiography-guided group. For outcome comparison, 617 control patients with LVEF >50% were included. After FFR, stenotic vessels per patient were significantly downgraded compared with the Angiography-guided group (1.43 ± 0.98 vs. 1.97 ± 0.84; P < 0.001). This was associated with lower revascularization rate (52% vs. 62%; P < 0.001) in the FFR-guided vs. the Angiography-guided group. All-cause death at 5 years of follow-up was significantly lower in the FFR-guided as compared with Angiography-guided group [22% vs. 31%. HR (95% CI) 0.64 (0.51-0.81); P < 0.001]. Similarly, rate of major adverse cardiovascular and cerebrovascular events (MACCE: composite of all-cause death, myocardial infarction, revascularization, and stroke) was significantly lower in the FFR-guided group [40% vs. 46% in the Angiography-guided group. HR (95% CI) 0.81 (0.67-0.97); P = 0.019]. Higher rates of death and MACCE were observed in patients with reduced LVEF compared with the control cohort. CONCLUSIONS In patients with reduced LVEF and CAD, FFR-guided revascularization was associated with lower rates of death and MACCE at 5 years as compared with the Angiography-guided strategy. This beneficial impact was observed in parallel with less coronary artery bypass grafting and more patients deferred to percutaneous coronary intervention or medical therapy.

[1]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[2]  E. Barbato,et al.  Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery , 2018, Circulation. Cardiovascular interventions.

[3]  P. Jüni,et al.  Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve , 2018, The New England journal of medicine.

[4]  E. Barbato,et al.  Visual and Quantitative Assessment of Coronary Stenoses at Angiography Versus Fractional Flow Reserve: The Impact of Risk Factors , 2017, Circulation. Cardiovascular imaging.

[5]  W. Wijns,et al.  Fractional flow reserve to guide and to assess coronary artery bypass grafting , 2016, European heart journal.

[6]  E. Barbato,et al.  Catheter-based functional metrics of the coronary circulation , 2017, Journal of Nuclear Cardiology.

[7]  B. Trimarco,et al.  Fractional Flow Reserve-Guided Revascularization in Patients With Aortic Stenosis. , 2016, The American journal of cardiology.

[8]  J. Rouleau,et al.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. , 2016, The New England journal of medicine.

[9]  W. Wijns,et al.  Impact of Right Atrial Pressure on Fractional Flow Reserve Measurements: Comparison of Fractional Flow Reserve and Myocardial Fractional Flow Reserve in 1,600 Coronary Stenoses. , 2016, JACC. Cardiovascular interventions.

[10]  P. Stella,et al.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. , 2015, European heart journal.

[11]  Volker Klauss,et al.  Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial , 2015, The Lancet.

[12]  C. V. van Mieghem,et al.  Revascularization Decisions in Patients With Stable Angina and Intermediate Lesions: Results of the International Survey on Interventional Strategy , 2014, Circulation. Cardiovascular interventions.

[13]  G. Gioia,et al.  Impact of Alpha- and Beta-Adrenergic Receptor Blockers on Fractional Flow Reserve and Index of Microvascular Resistance , 2014, Journal of Cardiovascular Translational Research.

[14]  Deepak L. Bhatt,et al.  Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. , 2014, American heart journal.

[15]  William Wijns,et al.  Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. , 2014, European heart journal.

[16]  B. Dimitrov,et al.  Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study , 2014, Circulation. Cardiovascular interventions.

[17]  G. Rioufol,et al.  Outcome Impact of Coronary Revascularization Strategy Reclassification With Fractional Flow Reserve at Time of Diagnostic Angiography: Insights From a Large French Multicenter Fractional Flow Reserve Registry , 2014, Circulation.

[18]  C. V. van Mieghem,et al.  Fractional Flow Reserve–Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery , 2013, Circulation.

[19]  M. Cerqueira,et al.  Identification of Therapeutic Benefit from Revascularization in Patients With Left Ventricular Systolic Dysfunction: Inducible Ischemia Versus Hibernating Myocardium , 2013, Circulation. Cardiovascular imaging.

[20]  P. Serruys,et al.  Do Differences in Repeat Revascularization Explain the Antianginal Benefits of Bypass Surgery Versus Percutaneous Coronary Intervention?: Implications for Future Treatment Comparisons , 2012, Circulation. Cardiovascular quality and outcomes.

[21]  D. Berman,et al.  Myocardial viability and survival in ischemic left ventricular dysfunction. , 2011, The New England journal of medicine.

[22]  S. Pavlović,et al.  Fractional flow reserve and myocardial viability as assessed by SPECT perfusion scintigraphy in patients with prior myocardial infarction , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[23]  J. Lupón,et al.  Mortalidad y causas de muerte en pacientes con insuficiencia cardiaca: experiencia de una unidad especializada multidisciplinaria , 2010 .

[24]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[25]  C. O'connor,et al.  A standardized definition of ischemic cardiomyopathy for use in clinical research. , 2002, Journal of the American College of Cardiology.

[26]  W. Wijns,et al.  Fractional Flow Reserve in Patients With Prior Myocardial Infarction , 2001, Circulation.

[27]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.